AxoGen: Rev generating; addressing peripheral nerve repair w portfolio of regenerative medicine products in US, Canada et al. Products incl. Avance Nerve Graft: off-the-shelf commercially avail processed human nerve allograft bridging severed nerves w/o comorbidities assoc w addl surgical site. 3Q18 revenue ($22.7M), up 41% vs $16M (3Q17).
Healthcare/Medical Devices
Based in...
Clinical Stage
Marketed, Phase III
Disease Space
Central Nervous System, Pain
Biotechnology, Medical Device
Public, USA
Market Cap
500MM +
13631 Progress Blvd
Suite 400
Alachua, FL 32615
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Solebury Trout Clients at Jefferies

New York, NY, United States, June 4 – June 7, 2019

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2017 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.